Johnson & Johnson (J&J) continues their shopping spree with the announcement that they will buy TearScience (maker of LipiFlow, LipiView).
Didn’t J&J just buy something else kind of big?
They did. Back in February they entered the cataract surgery market with the $4 billion dollar purchase of Abbott Medical Optics (AMO) whose portfolio includes, IOL’s, LASIK surgical systems, and artificial tears.
